Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1904 1
1907 1
1908 2
1909 3
1912 1
1914 1
1915 1
1918 1
1935 1
1938 1
1940 1
1942 1
1943 3
1944 1
1945 1
1946 1
1947 5
1948 1
1949 3
1950 6
1951 5
1952 2
1953 4
1954 4
1956 2
1957 1
1958 4
1959 7
1960 5
1961 4
1962 1
1963 7
1964 6
1965 1
1966 4
1967 7
1968 4
1969 9
1970 5
1971 5
1972 6
1973 5
1974 15
1975 11
1976 14
1977 12
1978 15
1979 17
1980 17
1981 37
1982 42
1983 29
1984 42
1985 29
1986 22
1987 32
1988 37
1989 32
1990 37
1991 33
1992 32
1993 28
1994 30
1995 46
1996 37
1997 29
1998 30
1999 40
2000 40
2001 46
2002 42
2003 31
2004 29
2005 37
2006 50
2007 47
2008 42
2009 48
2010 60
2011 88
2012 75
2013 79
2014 78
2015 96
2016 98
2017 96
2018 89
2019 101
2020 101
2021 97
2022 90
2023 64
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

2,342 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
Nuwer MR, MacDonald DB. Nuwer MR, et al. Among authors: macdonald db. Handb Clin Neurol. 2022;186:xi. doi: 10.1016/B978-0-12-819826-1.09997-X. Handb Clin Neurol. 2022. PMID: 35772903 No abstract available.
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM, Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE, Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM. Wen PY, et al. Among authors: macdonald dr. J Clin Oncol. 2023 Nov 20;41(33):5187-5199. doi: 10.1200/JCO.23.01059. Epub 2023 Sep 29. J Clin Oncol. 2023. PMID: 37774317
Frailty for Perioperative Clinicians: A Narrative Review.
McIsaac DI, MacDonald DB, Aucoin SD. McIsaac DI, et al. Among authors: macdonald db. Anesth Analg. 2020 Jun;130(6):1450-1460. doi: 10.1213/ANE.0000000000004602. Anesth Analg. 2020. PMID: 32384334 Review.
Painspotting.
MacDonald DI, Chesler AT. MacDonald DI, et al. Neuron. 2023 Sep 20;111(18):2773-2774. doi: 10.1016/j.neuron.2023.08.026. Neuron. 2023. PMID: 37734319
Canadian Association of Radiologists Guidance on Contrast Associated Acute Kidney Injury.
Macdonald DB, Hurrell C, Costa AF, McInnes MDF, O'Malley ME, Barrett B, Brown PA, Clark EG, Hadjivassiliou A, Kirkpatrick IDC, Rempel JL, Jeon PM, Hiremath S. Macdonald DB, et al. Can Assoc Radiol J. 2022 Aug;73(3):499-514. doi: 10.1177/08465371221083970. Epub 2022 May 24. Can Assoc Radiol J. 2022. PMID: 35608223 Free article.
Taurodontism.
MacDonald D. MacDonald D. Oral Radiol. 2020 Apr;36(2):129-132. doi: 10.1007/s11282-019-00386-1. Epub 2019 Apr 12. Oral Radiol. 2020. PMID: 30980345 Review.
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.
Crawford A, Haber L, Kelly MP, Vazzana K, Canova L, Ram P, Pawashe A, Finney J, Jalal S, Chiu D, Colleton CA, Garnova E, Makonnen S, Hickey C, Krueger P, DelFino F, Potocky T, Kuhnert J, Godin S, Retter MW, Duramad P, MacDonald D, Olson WC, Fairhurst J, Huang T, Martin J, Lin JC, Smith E, Thurston G, Kirshner JR. Crawford A, et al. Among authors: macdonald d. Sci Transl Med. 2019 Jun 19;11(497):eaau7534. doi: 10.1126/scitranslmed.aau7534. Sci Transl Med. 2019. PMID: 31217340
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
Skokos D, Waite JC, Haber L, Crawford A, Hermann A, Ullman E, Slim R, Godin S, Ajithdoss D, Ye X, Wang B, Wu Q, Ramos I, Pawashe A, Canova L, Vazzana K, Ram P, Herlihy E, Ahmed H, Oswald E, Golubov J, Poon P, Havel L, Chiu D, Lazo M, Provoncha K, Yu K, Kim J, Warsaw JJ, Stokes Oristian N, Siao CJ, Dudgeon D, Huang T, Potocky T, Martin J, MacDonald D, Oyejide A, Rafique A, Poueymirou W, Kirshner JR, Smith E, Olson W, Lin J, Thurston G, Sleeman MA, Murphy AJ, Yancopoulos GD. Skokos D, et al. Among authors: macdonald d. Sci Transl Med. 2020 Jan 8;12(525):eaaw7888. doi: 10.1126/scitranslmed.aaw7888. Sci Transl Med. 2020. PMID: 31915305
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.
Buske C, Tedeschi A, Trotman J, García-Sanz R, MacDonald D, Leblond V, Mahe B, Herbaux C, Matous JV, Tam CS, Heffner LT, Varettoni M, Palomba ML, Shustik C, Kastritis E, Treon SP, Ping J, Hauns B, Arango-Hisijara I, Dimopoulos MA. Buske C, et al. Among authors: macdonald d. J Clin Oncol. 2022 Jan 1;40(1):52-62. doi: 10.1200/JCO.21.00838. Epub 2021 Oct 4. J Clin Oncol. 2022. PMID: 34606378 Free PMC article. Clinical Trial.
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.
Waite JC, Wang B, Haber L, Hermann A, Ullman E, Ye X, Dudgeon D, Slim R, Ajithdoss DK, Godin SJ, Ramos I, Wu Q, Oswald E, Poon P, Golubov J, Grote D, Stella J, Pawashe A, Finney J, Herlihy E, Ahmed H, Kamat V, Dorvilliers A, Navarro E, Xiao J, Kim J, Yang SN, Warsaw J, Lett C, Canova L, Schulenburg T, Foster R, Krueger P, Garnova E, Rafique A, Babb R, Chen G, Stokes Oristian N, Siao CJ, Daly C, Gurer C, Martin J, Macdonald L, MacDonald D, Poueymirou W, Smith E, Lowy I, Thurston G, Olson W, Lin JC, Sleeman MA, Yancopoulos GD, Murphy AJ, Skokos D. Waite JC, et al. Among authors: macdonald d. Sci Transl Med. 2020 Jun 24;12(549):eaba2325. doi: 10.1126/scitranslmed.aba2325. Sci Transl Med. 2020. PMID: 32581132
2,342 results